increased circulating insulin level_Hrh3<tm1Kot>/Hrh3<tm1Kot>

http://metadb.riken.jp/0002079I129X1SvJC57BL6NHrh3tm1KotHrh3tm1KotHrh3tm1Kot

increased circulating insulin level_Hrh3<tm1Kot>/Hrh3<tm1Kot>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• histamine receptor H3
  http://metadb.riken.jp/db/mgi_rdf/MGI:2139279

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Hrh3<tm1Kot>/Hrh3<tm1Kot>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Hrh3<tm1Kot>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• involves: 129X1/SvJ * C57BL/6N

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• increased circulating insulin level
  http://purl.obolibrary.org/obo/MP_0002079

文献

http://purl.org/net/cito/citesAsAuthority

• Kazuhiko. Takahashi, et.al., Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype., The Journal of clinical investigation, 2002, 110
  http://rdf.ncbi.nlm.nih.gov/pubmed/12488429